S3 E2 Tracy Tranchitella, ND – Hormone Replacement Therapy and Removal of Black Box Warning

For decades, the Food and Drug Administration (FDA) had maintained a black box warning for hormone replacement therapy regarding estrogen. This often-prevented women from receiving appropriate estrogen hormone replacement therapy (HRT) either because of a history breast cancer or other health concern. This long-standing policy dated back decades to the Women’s Health Initiative study which failed to account for various individual factors such as type of estrogen, dose, and individual sensitiv...